참고문헌
- Abad A, Massuti B, Blanco E, Carrato A, Maurel J, Cervantes A, et al : Seventy-two hour epirubicin infusion plus quinidine in unresectable and metastatic adenocarcinoma of the pancreas : a phase II trial. Am J Clin Oncol 21 : 151-154, 1998 https://doi.org/10.1097/00000421-199804000-00012
- Allalunis-Turner MJ, Barron GM, Day RS III, Dobler K, Urtasun RC : Heterogeneity in response to treatment with buthionine sulfoximine or interferon in human malignant glioma cells. Int J Radiat Oncol Biol Phys 22 : 765-768, 1992 https://doi.org/10.1016/0360-3016(92)90520-R
- Beck WT, Grogan TM, Willman CL, Cordon-Cardo C, Parham DM, Kuttesch JF, et al : Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors : consensus recommendations. Cancer Res 56 : 3010-3020, 1996
- Bennis S, Ichas F, Robert J : Differential effects of verapamil and quinine on the reversal of doxorubicin resistance in a human leukemia cell line. Int J Cancer 62 : 283-290, 1995 https://doi.org/10.1002/ijc.2910620309
- Biedler JL, Riehm H, Peterson RH, Spengler BA : Membrane-mediated drug resistance and phenotypic reversion to normal growth behavior of Chinese hamster cells. J Natl Cancer Inst 55 : 671-680, 1975 https://doi.org/10.1093/jnci/55.3.671
- Dietzmann K, Bossanyi P, Franke DS : Expression of P-glycoprotein as a multiple resistance gene product in human protoplasmatic astrocytes and astrocytoma. Zentralbl Pathol 140 : 149-153, 1994
- Fojo AT, Shen DW, Mickley LA, Pastan I, Gottesman MM : Intrinsic drug resistance in human kidney cancer is associated with expression of a human multidrug-resistance gene. J Clin Oncol 5 : 1922-1927, 1987 https://doi.org/10.1200/JCO.1987.5.12.1922
- Gros P, Croop J, Housman D : Mammalian multidrug resistance gene : complete cDNA sequence indicates strong homology to bacterial transport proteins. Cell 47 : 371-380, 1986 https://doi.org/10.1016/0092-8674(86)90594-5
- Harrison DJ : Molecular mechanisms of drug resistance in tumors. J Pathol 175 : 7-12, 1995 https://doi.org/10.1002/path.1711750103
- Hu YP, Chapey C, Robert J : Relationship between the inhibition of azidopine binding to P-glycoprotein by MDR modulators and their efficiency in restoring doxorubicin intracellular accumulation. Cancer Lett 109 : 203-209, 1996 https://doi.org/10.1016/S0304-3835(96)04454-0
- Ichikawa M, Yoshimura A, Furukawa T, Sumizawa T, Nakazima Y, Akiyama S : Glycosylation of P-glycoprotein in a multidrug-resistant KB cell line, and in the human tissues. Biochim Biophys Acta 1073 : 309-315, 1991 https://doi.org/10.1016/0304-4165(91)90136-5
- Idriss HT, Hannun YA, Boulpaep E, Basavappa S : Regulation of volume-activated chloride channels by P-glycoprotein : phosphorylation has the final say! J Physiol 524 : 629-636, 2000 https://doi.org/10.1111/j.1469-7793.2000.00629.x
- Inaba M, Maruyama E : Reversal of resistance to vincristine in P388 leukemia by various polycyclic clinical drugs, with a special emphasis on quinacrine. Cancer Res. 48 : 2064-2067, 1988
- Kang MS, Kim HS, Han JA, Park SC, Kim WB, Park JG : Characteristics of human gastric carcinoma cell lines with induced multidrug resistance. Anticancer Res 17 : 3531-3536, 1997
- Kim JS, Amorino GP, Pyo H, Cao Q, Choy H : Radiation enhancement by the combined use of topoisomerase I inhibitors, RFS-2000 or CPT-11, and topoisomerase II inhibitor etoposide in human lung cancer cells. Radiother Oncol 62 : 61-67, 2002 https://doi.org/10.1016/S0167-8140(01)00465-0
- Kirches E, Oda Y, Von Bossanyi P, Diete S, Schneider T, Warich- Kirches M, et al : Mdr1 mRNA expression differs between grade III astrocytomas and glioblastomas. Clin Neuropathol 16 : 34-36, 1997
- Kohnoe S, Moriguchi S, Emi Y, Sakaguchi Y, Maehara Y, Ishida T, et al : Lung adenocarcinoma is more sensitive than gastric adenocarcinoma to anticancer drugs in vitro. Eur J Surg Oncol 17 : 47-50, 1991
- Lagneaux L, Delforge A, Carlier S, Massy M, Bernier M, Bron D : Early induction of apoptosis in B-chronic lymphocytic leukaemia cells by hydroxychloroquine : activation of caspase-3 and no protection by survival factors. Bri J Haematol 112 : 344-352, 2001 https://doi.org/10.1046/j.1365-2141.2001.02553.x
- Leyland-Jones B, Dalton W, Fisher GA, Sikic BI : Reversal of multidrug resistance to cancer chemotherapy. Cancer 72 : 3484-3488, 1993 https://doi.org/10.1002/1097-0142(19931201)72:11+<3484::AID-CNCR2820721615>3.0.CO;2-L
- Ling V, Thompson LH : Reduced permeability in CHO cells as a mechanism of resistance to colchicine. J Cell Physiol 83 : 103-116, 1974 https://doi.org/10.1002/jcp.1040830114
- Lum BL, Fisher GA, Brophy NA, Yahanda AM, Adler KM, Kaubisch S, et al : Clinical trials of modulation of multidrug resistance. Pharmacokinetic and pharmacodynamic considerations. Cancer 72 : 3502-3514, 1993 https://doi.org/10.1002/1097-0142(19931201)72:11+<3502::AID-CNCR2820721618>3.0.CO;2-N
- Meerum Terwogt JM, Malingre MM, Beijnen JH, ten Bokkel Huinink WW, Rosing H, Koopman FJ, et al : Coadministration of oral cyclosporin A enables oral therapy with paclitaxel. Clin Cancer Res 5 : 3379-3384, 1999
- Narasaki F, Matsuo I, Ikuno N, Fukuda M, Soda H, Oka M : Multidrug resistance-associated protein (MRP) gene expression in human lung cancer. Anticancer Res 16 : 2079-2082, 1996
- Pinedo HM, Giaccone G : P-Glycoprotein A Marker of Cancer-Cell Behavior. N Engl J Med 333 : 1417-1419, 1995 https://doi.org/10.1056/NEJM199511233332111
- Raderer M, Scheithauer W : Clinical trials of agents that reverse multidrug resistance. A literature review. Cancer 72 : 3553-3563, 1993 https://doi.org/10.1002/1097-0142(19931215)72:12<3553::AID-CNCR2820721203>3.0.CO;2-B
- Rhee HI, Kim JH, Kim CJ, Lee JK, Kwun BD : Does an Adjuvant Chemotherapy Really Help Patients with Glioblastoma? J Korean Neurosurg Soc 30 : 266-272, 2001
- Scala S, Dickstein B, Regis J, Szallasi Z, Blumberg PM, Bates SE : Bryostatin 1 affects P-glycoprotein phosphorylation but not function in multidrug-resistant human breast cancer cells. Clin Cancer Res 1 : 1581-1587, 1995
- Spoelstra EC, Dekker H, Schuurhuis GJ, Broxterman HJ, Lankelma J : P-glycoprotein drug efflux pump involved in the mechanisms of intrinsic drug resistance in various colon cancer cell lines. Evidence for a saturation of active daunorubicin transport. Biochem Pharmacol 41 : 349-359, 1991 https://doi.org/10.1016/0006-2952(91)90531-9
- Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y : Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 41 : 1967-1972, 1981
- Veneroni S, Zaffaroni N, Daidone MG, Benini E, Villa R, Silvestrini R : Expression of p-glycoprotein and in vitro or in vivo resistance to doxorubicin in and cisplatin in breast and ovarian cancers. Eur J Cancer 30A : 1002-1007, 1994
- Wolf R, Wolf D, Ruocco V : Antimalarials : Unapproved uses or indication. Clin Dermatol 18 : 17-35, 2000 https://doi.org/10.1016/S0738-081X(99)00092-9
- Ziemann C, Burkle A, Kahl GF, Hirsch-Ernst KI : Reactive oxygen species participate in mdr1b mRNA and P-glycoprotein overexpression in primary rat hepatocyte cultures. Carcinogenesis 20 : 407-414, 1999 https://doi.org/10.1093/carcin/20.3.407